Novozymes A/S (NVZMY)
OTC: NVZMY
· Real-Time Price · USD
65.22
-0.62 (-0.94%)
At close: Aug 14, 2025, 3:59 PM
65.23
0.02%
Pre-market: Aug 15, 2025, 08:38 AM EDT
Novozymes A/S Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 16.74B | 20.27B | 22.72B | 20.11B | 17.9B | 17.82B | 17.74B | 17.8B | 17.55B | 16.86B | 16.25B | 15.55B | 14.95B | 14.56B | 14.23B | 14B |
Cost of Revenue | 9.38B | 11.02B | 12.12B | 10.03B | 8.18B | 8.16B | 8.13B | 8.15B | 7.98B | 7.55B | 7.12B | 6.69B | 6.33B | 6.18B | 6.1B | 6.11B |
Gross Profit | 7.36B | 9.25B | 10.6B | 10.08B | 9.72B | 9.66B | 9.61B | 9.65B | 9.58B | 9.3B | 9.13B | 8.85B | 8.62B | 8.38B | 8.13B | 7.89B |
Operating Income | 1.71B | 2.97B | 3.56B | 3.92B | 4.55B | 4.11B | 4.38B | 4.62B | 4.54B | 4.25B | 4.06B | 3.94B | 4.01B | 4B | 3.8B | 3.67B |
Interest Income | n/a | 30M | 41M | 79M | 105M | 128M | 127M | 89M | 63M | 10M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 1.24B | 1.92B | 2.74B | 3.2B | 3.91B | 4.03B | 4.27B | 4.52B | 4.56B | 4.28B | 3.95B | 3.89B | 3.92B | 3.96B | 3.79B | 3.61B |
Net Income | 904.55M | 1.42B | 2.11B | 2.48B | 3.02B | 3.21B | 3.42B | 3.63B | 3.68B | 3.42B | 3.11B | 3.09B | 3.15B | 3.17B | 3.04B | 2.9B |
Selling & General & Admin | 3.3B | 3.93B | 4.29B | 3.77B | 3.32B | 3.29B | 3.34B | 3.31B | 3.22B | 3.29B | 3.12B | 2.96B | 2.79B | 2.51B | 2.42B | 2.33B |
Research & Development | 1.78B | 2.19B | 2.44B | 2.23B | 2.02B | 2.03B | 2.04B | 2.02B | 2B | 1.98B | 1.94B | 1.94B | 2.01B | 2.03B | 2.07B | 2.04B |
Other Expenses | 573.32M | 614.12M | 779.82M | 488.92M | 94M | 240M | -148M | -167M | -75M | -187M | 43M | 43M | -66M | -111M | -109M | -112M |
Operating Expenses | 5.65B | 6.74B | 7.34B | 6.31B | 5.26B | 5.38B | 5.22B | 5.17B | 5.15B | 5.08B | 5.1B | 4.94B | 4.74B | 4.43B | 4.38B | 4.26B |
Interest Expense | n/a | 120M | 120M | 158M | 269M | 149M | 344M | 327M | 216M | 248M | 53M | 44M | 44M | 12M | 12M | 12M |
Selling & Marketing Expenses | 2.39B | 2.83B | 3.07B | 2.7B | 2.37B | 2.33B | 2.37B | 2.33B | 2.27B | 2.32B | 2.2B | 2.08B | 1.94B | 1.72B | 1.65B | 1.59B |
Cost & Expenses | 15.03B | 17.76B | 19.46B | 16.34B | 13.44B | 13.54B | 13.35B | 13.32B | 13.13B | 12.64B | 12.22B | 11.64B | 11.07B | 10.61B | 10.48B | 10.37B |
Income Tax Expense | 338.59M | 507.89M | 641.69M | 728.35M | 870M | 810M | 826M | 872M | 870M | 850M | 826M | 795M | 779M | 783M | 749M | 712M |
Shares Outstanding (Basic) | 465M | 456.42M | 277.9M | 277.9M | 277.87M | 277.74M | 277.03M | 277M | 276.5M | 276.3M | 276.31M | 277.1M | 277.1M | 277.1M | 278.3M | 279.2M |
Shares Outstanding (Diluted) | 465M | 456.42M | 277.9M | 277.9M | 277.87M | 277.7M | 277.9M | 277.8M | 278M | 278.4M | 279.4M | 279.5M | 277.1M | 279.8M | 280.7M | 280.9M |
EPS (Basic) | 2.65 | 4.77 | 7.62 | 8.95 | 10.92 | 11.59 | 12.38 | 13.12 | 13.29 | 12.36 | 11.23 | 11.15 | 11.32 | 11.40 | 10.90 | 10.35 |
EPS (Diluted) | 2.65 | 4.76 | 7.60 | 8.92 | 10.88 | 11.55 | 12.32 | 13.04 | 13.20 | 12.28 | 11.15 | 11.08 | 11.25 | 11.33 | 10.85 | 10.30 |
EBITDA | 2.96B | 3.73B | 4.48B | 4.33B | 4.41B | 4.49B | 5B | 5.12B | 5.07B | 4.77B | 4.17B | 4.05B | 4.03B | 4.13B | 3.92B | 4.11B |
EBIT | 2.38B | 3.15B | 3.89B | 3.9B | 4.26B | 4.34B | 4.55B | 4.78B | 4.72B | 4.42B | 4.12B | 4.05B | 4.03B | 3.93B | 3.73B | 3.56B |
Depreciation & Amortization | 584.56M | 729.56M | 729.56M | 772.25M | 837M | 1.06B | 1.44B | 1.48B | 1.49B | 1.46B | 1.44B | 1.44B | 1.42B | 1.19B | 1.15B | 1.08B |